Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Palomaki

Showing results (131-140 of 275) with videos related to

Pageof 28
Sort By:
Prenatal Diagnosis|December 1, 1996
Refinements in managing maternal weight adjustment for interpreting prenatal screening resultsL M Neveux, G E Palomaki, D A Larrivee, et al.
The New England Journal of Medicine|April 2, 1998
Screening of maternal serum for fetal Down's syndrome in the first trimesterJ E Haddow, G E Palomaki, G J Knight, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 20, 2009
Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurementsGlenn E Palomaki, Jo Ellen S Lee, Jacob A Canick, et al.
Genetic Testing and Molecular Biomarkers|August 20, 2014
Maternal plasma DNA testing: experience of women counseled at a prenatal diagnosis centerBarbara M O'Brien, Edward M Kloza, Jacquelyn V Halliday, et al.
Journal of Medical Screening|May 26, 2001
Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screeningG J Knight, G E Palomaki, L M Neveux, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 13, 2017
The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy populationGlenn E Palomaki, Edward M Kloza, Barbara M O'Brien, et al.
Journal of Clinical Laboratory Analysis|September 9, 2006
Reference distributions for apolipoproteins AI and B and B/AI ratios: comparison of a large cohort to the world's literatureRobert F Ritchie, Glenn E Palomaki, Louis M Neveux, et al.
Prenatal Diagnosis|April 18, 2013
The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidiesJacob A Canick, Glenn E Palomaki, Edward M Kloza, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 9, 2019
Laboratory screening and diagnosis of open neural tube defects, 2019 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)Glenn E Palomaki, Caleb Bupp, Anthony R Gregg, et al.
The Journal of Applied Laboratory Medicine|July 8, 2020
Antimüllerian Hormone Levels Are Not Altered by Glucose Challenge or a MealGeralyn M Lambert-Messerlian, Joely A Straseski, Elizabeth E Eklund, et al.
Pageof 28

Showing results (131-140 of 275) with videos related to

Sort By:
Pageof 28
Prenatal Diagnosis|December 1, 1996
Refinements in managing maternal weight adjustment for interpreting prenatal screening resultsL M Neveux, G E Palomaki, D A Larrivee, et al.
The New England Journal of Medicine|April 2, 1998
Screening of maternal serum for fetal Down's syndrome in the first trimesterJ E Haddow, G E Palomaki, G J Knight, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 20, 2009
Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurementsGlenn E Palomaki, Jo Ellen S Lee, Jacob A Canick, et al.
Genetic Testing and Molecular Biomarkers|August 20, 2014
Maternal plasma DNA testing: experience of women counseled at a prenatal diagnosis centerBarbara M O'Brien, Edward M Kloza, Jacquelyn V Halliday, et al.
Journal of Medical Screening|May 26, 2001
Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screeningG J Knight, G E Palomaki, L M Neveux, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 13, 2017
The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy populationGlenn E Palomaki, Edward M Kloza, Barbara M O'Brien, et al.
Journal of Clinical Laboratory Analysis|September 9, 2006
Reference distributions for apolipoproteins AI and B and B/AI ratios: comparison of a large cohort to the world's literatureRobert F Ritchie, Glenn E Palomaki, Louis M Neveux, et al.
Prenatal Diagnosis|April 18, 2013
The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidiesJacob A Canick, Glenn E Palomaki, Edward M Kloza, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 9, 2019
Laboratory screening and diagnosis of open neural tube defects, 2019 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)Glenn E Palomaki, Caleb Bupp, Anthony R Gregg, et al.
The Journal of Applied Laboratory Medicine|July 8, 2020
Antimüllerian Hormone Levels Are Not Altered by Glucose Challenge or a MealGeralyn M Lambert-Messerlian, Joely A Straseski, Elizabeth E Eklund, et al.
Pageof 28